Free Trial
ASX:ACL

Australian Clinical Labs (ACL) Stock Price, News & Analysis

Australian Clinical Labs logo

About Australian Clinical Labs Stock (ASX:ACL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
$728.27 million
P/E Ratio
30.38
Dividend Yield
3.28%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. Australian Clinical Labs Limited was incorporated in 2020 and is headquartered in Clayton, Australia.

Receive ACL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Australian Clinical Labs and its competitors with MarketBeat's FREE daily newsletter.

ACL Stock News Headlines

Here’s How to Claim Your Stake in Elon’s Private Company, xAI
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
See More Headlines

ACL Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Australian Clinical Labs investors own include Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU) and Coles Group (COL).

Company Calendar

Ex-Dividend for 4/15 Dividend
3/26/2025
Record date for 4/15 Dividend
4/15/2025
Dividend Payable
4/15/2025
Today
5/24/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
ASX:ACL
CIK
N/A
Fax
N/A
Employees
5,115
Year Founded
N/A

Profitability

Trailing P/E Ratio
30.38
Forward P/E Ratio
N/A
P/E Growth
-0.36
Net Income
$23.93 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$696.37 million
Price / Cash Flow
N/A
Book Value
A$0.89 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$728.27 million
Optionable
Not Optionable
Beta
1.18
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (ASX:ACL) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners